Neurocrine Biosciences Inc (NAS:NBIX)
$ 136.53 -0.46 (-0.34%) Market Cap: 13.82 Bil Enterprise Value: 12.85 Bil PE Ratio: 36.60 PB Ratio: 5.08 GF Score: 88/100

Q3 2024 Neurocrine Biosciences Inc Earnings Call Transcript

Oct 30, 2024 / 12:00PM GMT
Release Date Price: $124.33 (+7.01%)
Operator

So please stand by your presented about to begin.

Good day, everyone, and welcome to today's Neurocrine Biosciences Reports Third quarter was at this time.

All participants are in listen only mode.

Later, we will have an opportunity to ask questions during the question and answer period register to ask a question at any time by pressing star one on your telephone keypad.

Please note that this call will be recorded.

I'll be standing by.

Should you need any assistance is my pleasure to turn today's call over to Todd Taylor, Vice President of Investor Relations.

Please go ahead.

Todd Tushla
Neurocrine Biosciences lnc - Investor Relations

Thank you and happy (of all) welcome to Neurocrine Biosciences Third Quarter 2024 earnings call.

With me are Carl Bass, our Chief Executive Officer, Matt Abernethy, Chief Financial Officer, Eric Benavides, Chief Commercial Officer, than either Roberts Chief Medical.

All know that today we will be making forward look statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot